Subsequent to PE Hub reporting that Anthem (NYSE:ANTM) is believed to be in late-stage talks to acquire Connecticut-based CareCentrix, Stephens analyst Scott Fidel re-affirmed its Overweight rating (PT, $330).
CareCentrix, backed by private equity firm Summit Partners, provides post-acute and home-based services, discharge management, and durable medical equipment.
He further adds that the CareCentrix deal, if completed, would represent the latest foray into home-based and post-acute care from the MCOs.
Fidel also notes as stated by PE Hub, CareCentrix was originally looking to secure a $1B deal valuation but that the current negotiating price has slipped to the $600-$700M range.
https://seekingalpha.com/news/3617449-anthem-reaffirmed-overweight-stephens-to-acquire-carecentrix
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.